- About Overview
- Diversity, Equity, and Inclusion
- Honors and Awards
- Facts and Figures
- Support the School
- Contact Us
- Organization Overview
- Dean’s Office
- Dean’s Office Overview
- PharmD Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Pharmacy Practice Partnerships
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Patient Care
Ding applies stem cell method to recreate cells lost in spinal cord injuries
By UCSF School of Pharmacy Editorial Staff / Thu Sep 17, 2015
Sheng Ding, PhD, is a stem cell scientist who uses novel small molecules to control and reprogram stem cell activities in various tissue types. Applying his groundbreaking techniques, he has previously succeeded in transforming skin cells into functional brain, heart, liver, and insulin-producing pancreas cells.
An August 26 article in Gladstone News highlights his recent research, explaining that Ding is "now applying his method to spinal cord injuries, regenerating cells that may someday allow patients with these injuries to regain mobility."
Ding, a professor in the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry, is also currently William K. Bowes, Jr. Distinguished Investigator at the Gladstone Institute of Cardiovascular Disease.
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.